Lucas Ruiter Kanamori, Emanuel Tenorio, Dora Babocs, Guilherme B Lima, Bernardo Mendes, Thanila A Macedo, Steven Maximus, Ying Huang, Gustavo S Oderich
{"title":"Clinical outcomes and quality of life measures among 5-year survivors of fenestrated-branched endovascular aortic repair.","authors":"Lucas Ruiter Kanamori, Emanuel Tenorio, Dora Babocs, Guilherme B Lima, Bernardo Mendes, Thanila A Macedo, Steven Maximus, Ying Huang, Gustavo S Oderich","doi":"10.1016/j.jvs.2025.01.210","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To report clinical outcomes and quality-of-life (QOL) changes among 5-year survivors of fenestrated-branched endovascular aortic repair (FB-EVAR) for complex abdominal (CAAA) and thoracoabdominal aortic aneurysms (TAAA).</p><p><strong>Summary background data: </strong>There is limited long-term data on FB-EVAR.</p><p><strong>Methods: </strong>All consecutive patients enrolled in a prospective, non-randomized study of FB-EVAR for CAAAs and TAAAs between 2013-2019 was analyzed (ClinicalTrials.gov NCT01937949 and NCT02089607). Patients who completed 5-year clinical and imaging follow-up were classified as 5-year survivors. Primary endpoint was the cumulative incidence of aortic repair failure (ARF), defined as a composite of aortic-related mortality (ARM), aortic rupture (ARR), conversion to open repair, and type I or III endoleak. Secondary endpoints included physical (PCS) and mental component (MCS) QOL scores.</p><p><strong>Results: </strong>Among 342 patients, 159 (70% male; median age 74-years (IQR 69-79-years) 5-year survivors were analyzed. Median follow-up was 63-months (IQR 59-82). Cumulative incidence of ARF at 5 years was 5.0% (95% CI 2.4-9.2). Cumulative incidences of ARR was 1.3% (95% CI 0.0-3.1) and type IIIB endoleaks was 2.4% (95% CI 0.0-5.2) at 5-years. There were no conversions to open repair or type IA endoleaks. PCS decline post-procedure improved but remained below baseline at 5-years. There was no change in MCS. The 8-year survival rate among patients who survived the first 5-years was 58.9% (95% CI 47.4-73.3%).</p><p><strong>Conclusion: </strong>The 5-year risk of FB-EVAR failure is 5% among survivors, with a low risk of aortic rupture or device integrity issues. Early decline in physical QOL scores improves but does not return to baseline values.</p>","PeriodicalId":17475,"journal":{"name":"Journal of Vascular Surgery","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Vascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jvs.2025.01.210","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To report clinical outcomes and quality-of-life (QOL) changes among 5-year survivors of fenestrated-branched endovascular aortic repair (FB-EVAR) for complex abdominal (CAAA) and thoracoabdominal aortic aneurysms (TAAA).
Summary background data: There is limited long-term data on FB-EVAR.
Methods: All consecutive patients enrolled in a prospective, non-randomized study of FB-EVAR for CAAAs and TAAAs between 2013-2019 was analyzed (ClinicalTrials.gov NCT01937949 and NCT02089607). Patients who completed 5-year clinical and imaging follow-up were classified as 5-year survivors. Primary endpoint was the cumulative incidence of aortic repair failure (ARF), defined as a composite of aortic-related mortality (ARM), aortic rupture (ARR), conversion to open repair, and type I or III endoleak. Secondary endpoints included physical (PCS) and mental component (MCS) QOL scores.
Results: Among 342 patients, 159 (70% male; median age 74-years (IQR 69-79-years) 5-year survivors were analyzed. Median follow-up was 63-months (IQR 59-82). Cumulative incidence of ARF at 5 years was 5.0% (95% CI 2.4-9.2). Cumulative incidences of ARR was 1.3% (95% CI 0.0-3.1) and type IIIB endoleaks was 2.4% (95% CI 0.0-5.2) at 5-years. There were no conversions to open repair or type IA endoleaks. PCS decline post-procedure improved but remained below baseline at 5-years. There was no change in MCS. The 8-year survival rate among patients who survived the first 5-years was 58.9% (95% CI 47.4-73.3%).
Conclusion: The 5-year risk of FB-EVAR failure is 5% among survivors, with a low risk of aortic rupture or device integrity issues. Early decline in physical QOL scores improves but does not return to baseline values.
期刊介绍:
Journal of Vascular Surgery ® aims to be the premier international journal of medical, endovascular and surgical care of vascular diseases. It is dedicated to the science and art of vascular surgery and aims to improve the management of patients with vascular diseases by publishing relevant papers that report important medical advances, test new hypotheses, and address current controversies. To acheive this goal, the Journal will publish original clinical and laboratory studies, and reports and papers that comment on the social, economic, ethical, legal, and political factors, which relate to these aims. As the official publication of The Society for Vascular Surgery, the Journal will publish, after peer review, selected papers presented at the annual meeting of this organization and affiliated vascular societies, as well as original articles from members and non-members.